Literature DB >> 17316570

Sensitization of TNF-induced cytotoxicity in lung cancer cells by concurrent suppression of the NF-kappaB and Akt pathways.

Xia Wang1, Wenshu Chen, Yong Lin.   

Abstract

Blockage of either nuclear factor-kappaB (NF-kappaB) or Akt sensitizes cancer cells to TNF-induced apoptosis. In this study, we investigated the undetermined effect of concurrent blockage of these two survival pathways on TNF-induced cytotoxicity in lung cancer cells. The results show that Akt contributes to TNF-induced NF-kappaB activation in lung cancer cells through regulating phosphorylation of the p65/RelA subunit of NF-kappaB. Although individually blocking IKK or Akt partially suppressed TNF-induced NF-kappaB activation, concurrent suppression of these pathways completely inhibited TNF-induced NF-kappaB activation and downstream anti-apoptotic gene expression, and synergistically potentiated TNF-induced cytotoxicity. Moreover, suppression of Akt inhibited the Akt-mediated anti-apoptotic pathway through dephosphorylation of BAD. These results indicate that concurrent suppression of NF-kappaB and Akt synergistically sensitizes TNF-induced cytotoxicity through blockage of distinct survival pathways downstream of NF-kappaB and Akt, which may be applied in lung cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17316570     DOI: 10.1016/j.bbrc.2007.02.030

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  24 in total

1.  Blocking NF-κB and Akt by Hsp90 inhibition sensitizes Smac mimetic compound 3-induced extrinsic apoptosis pathway and results in synergistic cancer cell death.

Authors:  Lang Bai; Shanling Xu; Wenshu Chen; Zi Li; Xia Wang; Hong Tang; Yong Lin
Journal:  Apoptosis       Date:  2011-01       Impact factor: 4.677

Review 2.  The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy.

Authors:  Yong Lin; Lang Bai; Wenjie Chen; Shanling Xu
Journal:  Expert Opin Ther Targets       Date:  2010-01       Impact factor: 6.902

Review 3.  Tumor necrosis factor and cancer, buddies or foes?

Authors:  Xia Wang; Yong Lin
Journal:  Acta Pharmacol Sin       Date:  2008-11       Impact factor: 6.150

Review 4.  Signal integration: a framework for understanding the efficacy of therapeutics targeting the human EGFR family.

Authors:  H Michael Shepard; Cathleen M Brdlik; Hans Schreiber
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

5.  Induction of G2/M phase arrest and apoptosis by ZGDHU-1 in A549 and RERF-LC-MA lung cancer cells.

Authors:  Xinfeng Shen; Zhen Wu; Sufeng Chen; Yu Chen; Jun Xia; Yaping Lv; Yonglie Zhou
Journal:  Oncol Lett       Date:  2016-06-09       Impact factor: 2.967

6.  Acquired activation of the Akt/cyclooxygenase-2/Mcl-1 pathway renders lung cancer cells resistant to apoptosis.

Authors:  Wenjie Chen; Lang Bai; Xia Wang; Shanling Xu; Steven A Belinsky; Yong Lin
Journal:  Mol Pharmacol       Date:  2009-11-23       Impact factor: 4.436

7.  Receptor-interacting protein 1 increases chemoresistance by maintaining inhibitor of apoptosis protein levels and reducing reactive oxygen species through a microRNA-146a-mediated catalase pathway.

Authors:  Qiong Wang; Wenshu Chen; Lang Bai; Wenjie Chen; Mabel T Padilla; Amy S Lin; Shaoqing Shi; Xia Wang; Yong Lin
Journal:  J Biol Chem       Date:  2014-01-14       Impact factor: 5.157

8.  A signaling pathway consisting of miR-551b, catalase and MUC1 contributes to acquired apoptosis resistance and chemoresistance.

Authors:  Xiuling Xu; Alexandria Wells; Mabel T Padilla; Kosuke Kato; Kwang Chul Kim; Yong Lin
Journal:  Carcinogenesis       Date:  2014-08-01       Impact factor: 4.944

9.  Akt-mediated eminent expression of c-FLIP and Mcl-1 confers acquired resistance to TRAIL-induced cytotoxicity to lung cancer cells.

Authors:  Xia Wang; Wenshu Chen; Weihua Zeng; Lang Bai; Yohannes Tesfaigzi; Steven A Belinsky; Yong Lin
Journal:  Mol Cancer Ther       Date:  2008-05       Impact factor: 6.261

10.  Attenuating Smac mimetic compound 3-induced NF-kappaB activation by luteolin leads to synergistic cytotoxicity in cancer cells.

Authors:  Lang Bai; Wenjie Chen; Xia Wang; Wei Ju; Shanling Xu; Yong Lin
Journal:  J Cell Biochem       Date:  2009-12-01       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.